Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Journey Medical Corp Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 8-K Quarterly results
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights"
07/26/2023 8-K Quarterly results
05/16/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/30/2023 10-K Annual Report for the period ended December 31, 2022
03/29/2023 8-K Quarterly results
01/27/2023 EFFECT Form EFFECT - Notice of Effectiveness:
01/20/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Press Release"
01/03/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
12/30/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
12/29/2022 SC 13G/A B. Riley Financial, Inc. reports a 4.9% stake in Journey Medical Corporation
08/17/2022 SC 13G Fortress Biotech, Inc. reports a 56.9% stake in Journey Medical Corporation
07/22/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "JOURNEY MEDICAL CORPORATION 2015 STOCK PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT"
06/21/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDMENT TO THE JOURNEY MEDICAL CORPORATION 2015 STOCK PLAN"
05/10/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/10/2022 8-K Quarterly results
Docs: "Journey Medical Corporation Reports First Quarter 2022 Financial Results and Recent Corporate Highlights"
04/28/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/28/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/28/2022 10-K Annual Report for the period ended December 31, 2021
03/23/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Journey Medical Corporation Reports Full-Year 2021 Financial Results and Recent Corporate Highlights"
02/11/2022 SC 13G B. Riley Financial, Inc. reports a 5.6% stake in Journey Medical Corporation
01/13/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Asset Purchase Agreement between VYNE Therapeutics Inc. and Journey Medical Corporation",
"Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stabilizing Technology ™ Franchise from VYNE Therapeutics, Inc."
12/15/2021 10-Q Quarterly Report for the period ended September 30, 2021
12/10/2021 8-K Quarterly results
11/12/2021 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financi...
Docs: "Underwriting Agreement, between Journey Medical Corporation and B. Riley Securities, as representative of the underwriters named therein",
"Second Amended and Restated Certificate of Incorporation of Journey Medical Corporation",
"Opinion of Alston & Bird LLP"
11/12/2021 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/12/2021 CERT Form CERT - Certification by an exchange approving securities for listing:
11/12/2021 8-A12B Form 8-A12B - Registration of securities [Section 12(b)]:
11/10/2021 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
11/10/2021 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy